Abstract Interferon beta (IFNβ) therapy for multiple sclerosis (MS) is associated with a potential for the development of neutralising antibodies (NAbs) that negatively affect therapy. ... more »
|
|||||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Sunday, August 19
|
||||